Palvella Therapeutics Inc...

NASDAQ: PVLA · Real-Time Price · USD
47.12
1.02 (2.21%)
At close: Aug 15, 2025, 3:59 PM
47.30
0.39%
After-hours: Aug 15, 2025, 04:10 PM EDT

Palvella Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a 25.9M 31.42M
Cost of Revenue
n/a n/a 2.78M 2.37M
Gross Profit
n/a n/a 23.12M 29.05M
Operating Income
-14.1M -11.87M -43.47M -51.83M
Interest Income
n/a 6.26M 721K 4K
Pretax Income
-17.43M 18.69M -33.28M -45.74M
Net Income
-17.43M 18.69M -27.55M -45.74M
Selling & General & Admin
5.94M 3.08M 16.38M 16.68M
Research & Development
8.15M 8.79M 50.21M 64.2M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
14.1M 11.87M 66.6M 80.88M
Interest Expense
4.32M n/a n/a n/a
Selling & Marketing Expenses
n/a n/a 12.23M n/a
Cost & Expenses
14.1M 11.87M 69.38M 83.25M
Income Tax Expense
n/a n/a -1.03M n/a
Shares Outstanding (Basic)
2.23M 1.27M 930.35K 806.84K
Shares Outstanding (Diluted)
2.23M 1.27M 930.35K 806.84K
EPS (Basic)
-7.83 14.74 -29.61 -56.69
EPS (Diluted)
-7.83 14.74 -29.61 -56.69
EBITDA
-13.12M 18.69M -30.5M -43.37M
EBIT
-13.12M 18.69M -33.28M -45.74M
Depreciation & Amortization
n/a n/a 2.78M 2.37M